Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT00932893
Brief Title: An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

First Submitted : June 30, 2009
First Submitted that Met QC Criteria : July 2, 2009
First Posted : July 3, 2009 (Estimate)

Results First Submitted : March 13, 2013
Results First Submitted that Met QC Criteria : June 4, 2013
Results First Posted : June 6, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : October 31, 2016
Last Update Posted : January 2, 2017 (Estimate)